Basics Recursion Pharmaceuticals, Inc. IPO Date: April 16, 2021 Sector: Healthcare Industry: Biotech Market Cap: $2.92B Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 3.91% Avg Daily Range (30 D): $0.26 | 4.62% Avg Daily Range (90 D): $0.18 | 3.31% Institutional Daily Volume Avg Daily Volume: 7.29M Avg Daily Volume (30 D): 53.15M Avg Daily Volume (90 D): 33.67M Trade Size Avg Trade Size (Sh.): 220 Avg Trade Size (Sh.) (30 D): 508 Avg Trade Size (Sh.) (90 D): 420 Institutional Trades Total Inst.Trades: 2,453 Avg Inst. Trade: $2.27M Avg Inst. Trade (30 D): $2.46M Avg Inst. Trade (90 D): $2.2M Avg Inst. Trade Volume: .28M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.87M Avg Closing Trade (30 D): $7.62M Avg Closing Trade (90 D): $5.4M Avg Closing Volume: 478.2K     News Oct 20, 2025 @ 4:07 PM Recursion Pharmaceuticals (RXRX) CEO Sells 100,000... Source: Cory Renauer Oct 16, 2025 @ 1:31 PM Is Recursion Pharmaceuticals a Millionaire Maker? Source: Keith Speights Oct 14, 2025 @ 3:41 PM Absci Stock Offers High-Risk AI Biotech Exposure W... Source: Nathan Reiff Sep 29, 2025 @ 1:02 PM Nvidia Has Invested in These 6 Companies. Should Y... Source: Matthew Benjamin Sep 28, 2025 @ 1:32 PM The Biotech Stock That's Too Risky for Most Invest... Source: Cory Renauer Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.82 $-.41 $-.5 Diluted EPS $-1.82 $-.41 $-.5 Revenue $ 64.6M $ 19.22M $ 14.75M Gross Profit $ -2.27M $ -.94M $ -7.08M Net Income / Loss $ -649.13M $ -171.9M $ -202.49M Operating Income / Loss $ -649.72M $ -176.23M $ -191.37M Cost of Revenue $ 66.86M $ 20.16M $ 21.83M Net Cash Flow $ 51.09M $ 24.69M $ -93.87M PE Ratio